A recent in vitro study indicated that HGF promotes resistance to MEK inhibitors by increasing the expression of the proteins, Bcl-2-like 11 (BIM)—extra-long (EL) and Bcl-2 Modifying Factor (BMF), in uveal melanoma cells (Schoumacher et al., 2016). The gene discussed is BCL2L11; the disease is uveal melanoma.